Article

Mmarketwatch.com on 2020-07-13 13:37

Lannett to cut jobs following FDA approval of competing generic drug

Shares of Lannett Company Inc. undefined gained 0.2% after the company said it will cut 80 positions, about 8.5% of its total workforce, over concerns ...

Related news

Lannett secures 'milestone' FDA approval for branded local anesthetic bizjournals.com
First generic EpiPen gets FDA approval CNN
FDA gives Lannett more time to fight for generic ADHD drug bizjournals.com
Northeast Philadelphia Airport
FDA to withdraw approval of Lannett's generic ADHD drug bizjournals.com
Teva gets FDA approval for first generic EpiPen bizjournals.com
Biogen scores FDA approval for generic eye disease biologic bizjournals.com
Teva shares down 13% following FDA approval of generic Copaxone bizjournals.com
Clayton Pharmaceuticals gets FDA approval for generic ulcer treatment bizjournals.com
FDA approves 2 Lannett products bizjournals.com
FDA Talks Generic Drugs: A Look at the Generic Drug Approval Process from the Agency’s Perspective jdsupra.com
Lannett & Chinese partner developing generic insulin product bizjournals.com
Northeast Philadelphia Airport , China
Raleigh's Merz gets FDA approval for Botox-competing treatment bizjournals.com
Durham , United States , North America , Raleigh
FDA Approves Teva's Generic Version of Mylan's EpiPen Haaretz
Canada , Europe , North America , Israel
MPerrigo says the FDA has given tentative approval to generic acne gel marketwatch.com
MImpax Labs stock surges 4.4% on FDA approval of generic kidney disease medication Renvela marketwatch.com
Teva gets FDA approval for 1st generic nasal spray of overdose reversal drug timesofisrael.com
New York , Israel
FDA approves generic EpiPen nwaonline.com
Illinois
South Jersey pharma firm gets FDA approval for generic skin cream bizjournals.com